Here's the Major Earnings Before the Open Tomorrow
A Glimpse of Apellis Pharmaceuticals's Earnings Potential
RBC Capital Reiterates Sector Perform on Apellis Pharmaceuticals, Maintains $25 Price Target
Apellis Pharmaceuticals Analyst Ratings
Evercore Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating
Earnings Preview: APLS to Report Financial Results Pre-market on November 05
$Apellis Pharmaceuticals(APLS.US)$ is scheduled to release its financial results pre-market on November 05 ET. Earnings PreviewAnalysts estimate $Apellis Pharmaceuticals(APLS.US)$ to post revenue of